Recap: InMode Q4 Earnings
Shares of InMode (NASDAQ:INMD) fell 0.1% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 104.35% over the past year to $0.94, which beat the estimate of $0.75.
Revenue of $75,187,000 up by 59.97% year over year, which beat the estimate of $70,760,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Feb 10, 2021
Time: 08:30 AM
ET Webcast URL: https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10151158&linkSecurityString=e064a3345e
Technicals
Company's 52-week high was at $69.91
52-week low: $13.14
Price action over last quarter: Up 64.13%
Company Description
InMode Ltd is a provider of minimally-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions are designed to address three energy-based treatment categories including face and body contouring, medical aesthetics and women's health. The technologies offered by the company include BodyTite, Contoura, EmbraceRF, Optimas, and Votiva among others.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
